Scig (Sub-Q)
SCig is another method of delivery for IgG therapy. It stands for Subcutaneous (under the skin) delivery of immunoglobulin replacement therapy. It simplifies treatment for patients who might have poor venous access or reactions to IVig therapy. The patient has the ability to lead a more independent and flexible life by administering SCig therapy daily, weekly, bi-monthly, or whatever schedule you and your physician decide upon based on your condition, weight and age.
The patient will experience fewer, if any, side effects. SCig can be administered anywhere below the surface of the skin where you can “pinch an inch”, and not into a vein. Thighs, upper arms, stomach or hips are the most common infusion sites and can be rotated. While administering the dose, the patient can remain mobile and move about by using a small, portable pump.
Patients are usually given their initial dose(s) in the physician’s office, and trained by a nurse until they have a level of comfort to self-administer the therapy. They may also have a nurse visit in their home for training. A patient is usually trained and ready to go in 1-4 sessions.
Because of the more frequent treatments, this method also makes the patient less prone to infections. Sub Q is about comfort, convenience and quality of life.
Sub Q Resources
How to Sub Q
Sub Q Resource Center
Vivaglobin®
BioRx Offers Vivaglobin® to Patients with Primary Immune Deficiency Disorders
www.Vivaglobin.com
|
